Journal article
Tamoxifen for Breast Cancer Risk Reduction
Abstract
BACKGROUND: In cost-effectiveness analysis (CEA), the effects of health-care interventions on multiple health dimensions typically require consideration of both quantity and quality of life.
OBJECTIVES: To explore the impact of alternative approaches to quality-of-life adjustment using patient preferences (utilities) on the outcome of a CEA on use of tamoxifen for breast cancer risk reduction.
Authors
Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
Journal
Medical Care, Vol. 46, No. 9, pp. 946–953
Publisher
Wolters Kluwer
Publication Date
9 2008
DOI
10.1097/mlr.0b013e318179250f
ISSN
0025-7079